David Ian Marks
Impact in
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.2%
Papers in
- Hematology 178
- Hematopoietic Stem Cell Transplantation 120
- Acute Myeloid Leukemia Research 60
- Chronic Myeloid Leukemia Treatments 51
-
- Acute Lymphoblastic Leukemia research 116
- Co-authors
- Hillard Michael Lazarus (38 shared papers)Lucy Yardley (1 shared paper)Martin S. Tallman (21 shared papers)Mark Robert Litzow (24 shared papers)Adele Kay Fielding (26 shared papers)Richard Champlin (9 shared papers)Jacob M. Rowe (17 shared papers)Andrew McMillan (17 shared papers)
- Journals
- Transplantation and Cellular Therapy (82 papers)Blood (43 papers)British Journal of Haematology (27 papers)Blood Advances (12 papers)Journal of Clinical Oncology (7 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David Ian Marks
259 papers receiving 16.6k citations
David Ian Marks's Hit Papers
Peers
Comparison fields: 5 of 181
- Hematology 10.2k
- Genetics 2.9k
- Transplantation 526
- Public Health, Environmental and Occupational Health 5.5k
- Oncology 3.9k
Countries citing papers authored by David Ian Marks
This map shows the geographic impact of David Ian Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ian Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ian Marks more than expected).
Fields of papers citing papers by David Ian Marks
This network shows the impact of papers produced by David Ian Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ian Marks. The network helps show where David Ian Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside David Ian Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia Hit paper breakdown → | 2004 | 898 |
| 2 | Research Methods for Clinical and Health Psychology Hit paper breakdown → | 2004 | 690 |
| 3 | Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Hit paper breakdown → | 2006 | 688 |
| 4 | In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) Hit paper breakdown → | 2007 | 657 |
| 5 | Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation Hit paper breakdown → | 2017 | 544 |
| 6 | 2010 | 476 | |
| 7 | Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis Hit paper breakdown → | 2016 | 456 |
| 8 | 2010 | 409 | |
| 9 | 2010 | 370 | |
| 10 | 2009 | 326 | |
| 11 | Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation Hit paper breakdown → | 2015 | 324 |
| 12 | 2011 | 305 | |
| 13 | 2013 | 301 | |
| 14 | 2009 | 237 | |
| 15 | Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. | 2002 | 228 |
| 16 | 2009 | 212 | |
| 17 | 2020 | 197 | |
| 18 | 2011 | 193 | |
| 19 | 2017 | 189 | |
| 20 | 2012 | 179 |
About David Ian Marks
David Ian Marks is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Oncology and Pediatrics, Perinatology and Child Health, having authored 266 papers that have together received 17.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (120 papers), Acute Lymphoblastic Leukemia research (116 papers), Acute Myeloid Leukemia Research (60 papers), Chronic Myeloid Leukemia Treatments (51 papers), Childhood Cancer Survivors' Quality of Life (30 papers), CAR-T cell therapy research (27 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (22 papers). The work is most often cited by research in Hematology (10.2k citations), Genetics (2.9k citations), Transplantation (526 citations), Public Health, Environmental and Occupational Health (5.5k citations) and Oncology (3.9k citations). David Ian Marks has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Hillard Michael Lazarus, Lucy Yardley, Martin S. Tallman, Mark Robert Litzow, Adele Kay Fielding, Richard Champlin, Jacob M. Rowe, Andrew McMillan, Anthony H. Goldstone and Selina M. Luger. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, British Journal of Haematology, Blood Advances and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.